#PFIZER BOOSTER SHOT FULL#

'It's one of the reasons why, you know, we don't want to have to choose between giving our population boosters, if it's required, and vaccinating the rest of the world.' 'We as a country have a vested interest in getting the rest of the world vaccinated,' Murthy said. Murthy also said that the question of whether it was ethical for a third booster shot to be recommended while there is a major vaccine supply shortage in the developing world was a 'critical question' because the ability to reduce the likelihood of future variants developing depends on tamping down spread of the virus around the world. 'Ultimately, that collective information is what will drive any decision about boosters.' Murthy said government agencies would be 'looking at the whole breadth of data that will come from companies, that will come from cohorts that the CDC is now following, where they're tracking whether or not there is any waning in immunity or increase in breakthrough rates. 'But at this point, I want to be very clear: People do not need to go out and get a booster shot.' 'This data from Pfizer, we've been in talks with them about what they're seeing with regard to their studies related to boosters,' Murthy said, when asked about Pfizer's new data. Surgeon general: 'People do not need to go out and get a booster shot'ДЄt this point, the decision on if and when booster shots are necessary will be made by agencies such as the FDA and CDC, Murthy said on CNN on Wednesday.

He mentioned how the delta variant is the 'most transmissible' yet seen and now represents about 83% of sequenced COVID-19 cases in the United States. 'Pending regulatory approval, we also plan to start an immunogenicity and safety study in August to evaluate an updated version of our vaccine specifically designed to target the delta variant,' Dolsten said.

#PFIZER BOOSTER SHOT FULL#

'We continue to believe it is likely that a third-dose booster may be needed within six to 12 months after full vaccination to maintain the highest level of protection, and studies are underway to evaluate the safety and immunogenicity of a third dose,' Dolsten said, adding that data suggest antibody levels appear to decline around eight months after receiving a second dose of vaccine.

In order for third doses to be administered to people in the United States, the emergency use authorization that the FDA issued for the vaccine would either need to be amended or, if the vaccine were fully FDA approved, a third dose could be given off label. 'We are in ongoing discussions with regulatory agencies regarding a potential third-dose booster of the current vaccine and, assuming positive results, anticipate an emergency use authorization submission as early as August,' Dolsten said. Pfizer said it anticipates submitting data on a third dose of its coronavirus vaccine to the FDA as soon as next month, Dolsten said during Wednesday's earnings call. Pfizer to submit third-dose vaccine data to FDA soon Vivek Murthy repeated that point Wednesday morning, telling CNN's Poppy Harlow, 'People do not need to go out and get a booster shot.' The company also specified it would seek emergency use authorization under the US Food and Drug Administration for a third dose in August.Д«ut in an unusual move, two top federal agencies said at the time Americans don't need third doses quite yet and that it was not up to companies alone to decide when an additional dose might be needed. The data also show that antibody levels are much higher against the original coronavirus variant and the Beta variant, first identified in South Africa, after a third dose.Д®arlier this month, Pfizer announced it has seen waning immunity from its coronavirus vaccine, saying it is picking up its efforts to develop a third dose that will protect people from variants. CDC Director Rochelle Walensky addresses the changed mask guidance due to rising COVID-19 cases on 'Good Morning America.'

Pfizer booster shot